Syncom Formulations (India) submits newspaper advertisement

17 Aug 2021 Evaluate

Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(l)(b) of SEBI (LODR) Regulations, 2015, Syncom Formulations (India) has informed regarding extract of Standalone Un-Audited Quarterly Financial Results for the Quarter ended 30th June, 2021 was approved in 02/2021-22 Meeting of Board of Directors held on Saturday, 14th August, 2021 at 2.00 pm at the Corporate Office of the company at 207, Saket Nagar, Indore (M.P) 452018. The company has enclosed the newspaper advertisement published on 15/08/2021 in Free Press Journal English edition and Marathi (vernacular) Newspaper.

The above information is a part of company’s filings submitted to BSE.



Syncom Formulations Share Price

11.95 0.33 (2.84%)
18-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1778.75
Dr. Reddys Lab 1294.25
Cipla 1268.20
Zydus Lifesciences 898.75
Lupin 2302.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×